# Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer

> **NCT01706185** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 156 (actual)

## Conditions studied

- Neoplasms, Urinary Bladder

## Interventions

- **OTHER:** Data acquisition and analysis

## Key facts

- **NCT ID:** NCT01706185
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01-15
- **Primary completion:** 2008-01-15
- **Final completion:** 2008-01-15
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01706185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01706185, "Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01706185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*